CoChat

Characterization of the β‐adrenoceptor subtype involved in mediation of glucose transport in L6 cells

Open access
Nevzorova, Julia, Bengtsson, Tore, Evans, Bronwyn A, Summers, Roger J · 2002 · British Journal of Pharmacology
Cited by 72

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

The receptor that mediates the increase in glucose transport (GT) in response to β‐adrenoceptor (β‐AR) agonists was characterized in the rat skeletal muscle cell line L6, using the 2‐deoxy‐[3 H]‐D‐glucose assay. The β 3‐AR agonist BRL37344 (pEC 50=6.89±0.21), the β‐AR agonist isoprenaline (pEC 50=8.99±0.24) and the β 2‐AR agonist zinterol (pEC 50=9.74±0.15) increased GT as did insulin (pEC 50=6.93±0.15). The highly selective β 3‐AR agonist CL316243 only weakly stimulated GT. The pK B values calculated from the shift of the pEC 50 values of the agonists in the presence of the β 1‐AR selective antagonist CGP 20712A or the β 3‐AR selective antagonist SR 59230A were not indicative of activation of β 1‐ or β 3‐ARs. Only (−)‐propranolol and the β 2‐AR selective antagonist ICI 118551 caused marked rightward shifts of CR curves to isoprenaline (pK B=10.2±0.2 and 9.6±0.3), zinterol (pK B=9.0±0.1 and 9.4±0.3) and BRL 37344 (pK B=9.4±0.3 and 8.4±.2), indicating participation of β 2‐ARs. The pharmacological analysis was supported by reverse transcription and polymerase chain reaction analysis of L6 mRNA, which showed high levels of expression of β 2‐AR but not β 1‐ or β 3‐AR in these cells. Forskolin and dibutyryl cyclic AMP produced negligible increases in GT while the phosphatidylinositol‐3 kinase inhibitor, wortmannin, significantly decreased both insulin‐ and zinterol‐stimulated GT, suggesting a possible interaction between the insulin and β 2‐AR pathways. This study demonstrates that β 2‐ARs mediate the increase in GT in L6 cells to β‐AR agonists, including the β 3‐AR selective agonist BRL 37344. This effect does not appear to be directly related to increases in cyclic AMP but requires P13K. British Journal of Pharmacology (2002) 137, 9–18. doi:10.1038/sj.bjp.0704845

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjp.0704845

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

Metadata

Authors
Nevzorova, J., Bengtsson, T., Evans, B. A., & Summers, R. J.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2002-09
Volume
137
Issue
1
Pages
9-18
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2065811593
Cited by
72
References
1
FWCI
0.54
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.